Biogen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	1,609	1,632	1,161	3,047	1,556	4,001
Depreciation & Amortization	763.7	673.2	494.8	518.4	487.7	457.2
Loss (Gain) From Sale of Assets	-	-88.6	-	-503.7	-	-92.5
Asset Writedown & Restructuring Costs	43.5	60.2	-	119.6	647.3	284.7
Loss (Gain) From Sale of Investments	112.4	101.4	277.1	-1,240	826.8	-681.8
Loss (Gain) on Equity Investments	-	-	-	-2.6	-34.9	-3.3
Stock-Based Compensation	306.3	291.2	264.2	254.1	238.6	198.3
Other Operating Activities	539.8	361.1	-1.3	81.4	63.8	253.8
Change in Accounts Receivable	169.6	222.3	61.3	-203.4	324.8	2.8
Change in Inventory	-101.7	-273.8	-130.9	-320.2	-462.4	-316.3
Change in Other Net Operating Assets	-240.8	-182.2	-280.1	-224.4	-238.7	193.8
Operating Cash Flow	2,454	2,876	1,547	1,384	3,640	4,230
Operating Cash Flow Growth	15.35%	85.85%	11.77%	-61.97%	-13.95%	-40.24%
Capital Expenditures	-149.2	-153.7	-277	-240.3	-258.1	-424.8
Sale of Property, Plant & Equipment	-	-	-	582.6	-	-
Cash Acquisitions	-	-1,075	-6,926	-	-	-141.8
Divestitures	-	-	-	-	28.1	-
Sale (Purchase) of Intangibles	-42.3	-117.5	-34.4	-2.9	-36.8	-127
Investment in Securities	13.6	551.5	3,148	1,213	-309.8	111.9
Other Investing Activities	19.9	-4.7	-11.3	24.4	12.9	-26.9
Investing Cash Flow	-158	-799.2	-4,101	1,577	-563.7	-608.6
Long-Term Debt Issued	-	-	997.2	-	-	2,967
Long-Term Debt Repaid	-	-650	-809.9	-1,002	-170	-1,500
Net Debt Issued (Repaid)	-16.9	-650	187.3	-1,002	-170	1,467
Repurchase of Common Stock	-	-	-	-750	-1,800	-6,679
Other Financing Activities	-140.1	-33.5	-38	4.9	-116.2	-61
Financing Cash Flow	-157	-683.5	149.3	-1,747	-2,086	-5,273
Foreign Exchange Rate Adjustments	25	-67.7	35.1	-55.7	-59.8	69
Net Cash Flow	2,164	1,325	-2,369	1,158	930.2	-1,583
Free Cash Flow	2,304	2,722	1,270	1,144	3,382	3,805
Free Cash Flow Growth	18.33%	114.28%	11.03%	-66.17%	-11.12%	-42.03%
Free Cash Flow Margin	22.89%	28.13%	12.91%	11.24%	30.80%	28.30%
Free Cash Flow Per Share	15.73	18.66	8.72	7.84	22.61	23.59
Cash Interest Paid	245.4	245.4	252.2	262.5	280.8	272.7
Cash Income Tax Paid	355.1	355.1	740.7	932.9	247.9	906.7
Levered Free Cash Flow	2,138	3,267	971.06	1,393	2,208	2,878
Unlevered Free Cash Flow	2,300	3,423	1,125	1,547	2,365	3,011
Change in Working Capital	-920.6	-155.2	-648.7	-890.3	-145.5	-187.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.